In Memorium
In Memorium
Assessing Patient Accrual to Cooperative Group Lung Cancer Trials
Random Survival Forests
Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung Cancer
The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth
Survival Benefits from Follow-Up of Patients with Lung Cancer
Lung Cancer Incidence and Survival in England
Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort
Association of Cytidine Deaminase and Xeroderma Pigmentosum Group D Polymorphisms with Response, Toxicity, and Survival in Cisplatin/Gemcitabine-Treated Advanced Non-small Cell Lung Cancer Patients
Clinical Implications of High MET Gene Dosage in Non-Small Cell Lung Cancer Patients without Previous Tyrosine Kinase Inhibitor Treatment
Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer
Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer
Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer
Respiratory Gating Techniques for Optimization of Lung Cancer Radiotherapy
S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy
Skin Toxicities Compromise Prolonged Pemetrexed Treatment
Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer
Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer
Phase II Trials of Imatinib Mesylate and Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma
Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation
Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy
Combination Chemotherapy with Doxorubicin, Vincristine, Cyclophosphamide, and Platinum Compounds for Advanced Thymic Carcinoma
Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib
Percutaneous Balloon Pericardiotomy for Recurrent Malignant Pericardial Effusion
Erlotinib in Metastatic Bronchopulmonary Mucoepidermoid Carcinoma
The Role of Postoperative Radiotherapy After Resection of Stage III Thymoma
Postoperative Radiotherapy for Completely Resected Stage II or III Thymoma
A Practical Guide to Measure “All” Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria?
Reply to the Letter to the Editor Entitled A Practical Guide to Measure “All” Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria?
How Should We Use Bevacizumab in Patients with Non-small Cell Lung Cancer?
Techniques of Surgery and Radiotherapy for Multimodal Treatment of Pleural Mesothelioma